Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Complex and Mixed

Explore clinical trials studying Neoplasms, Complex and Mixed. Study availability and eligibility vary by location and protocol.

399 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Complex and Mixed trial results

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 28 locations
View Trial Details
Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

NCT06942039

Conditions
Atypical Teratoid Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +38 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba (CCMB) Winnipeg, Manitoba, Canada
  • IWK Health Centre Halifax, Nova Scotia, Canada
View Trial Details
Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

NCT04634357

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center Boston, Massachusetts, United States
View Trial Details
Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199

Conditions
Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +30 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View Trial Details

Related conditions